Giovanni Caforio, chairman of the board of directors at Novartis AG, highlighted that from its early investment in the Shanghai campus to thriving partnerships with leading hospitals and research institutes, Novartis has become part of the fabric of this dynamic city.

In his eyes, Shanghai truly stands out on the global stage, with its robust scientific ecosystem, talent, strong commitment to healthcare innovation, and willingness to embed breakthrough technologies such as AI.